Skip to main content

Acute Coronary Syndrome clinical trials at UCSD
2 in progress, 1 open to new patients

  • Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

    open to eligible people ages 18 years and up

    This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI), including those managed with percutaneous coronary intervention (PCI) or medically managed.

    San Diego, California and other locations

  • LEADERS FREE II: BioFreedom™ Pivotal Study

    Sorry, in progress, not accepting new patients

    This study aims to confirm non-inferiority of the BioFreedom™ Drug Coated Stent to the Gazelle™ Bare Metal Stent arm of the Leaders Free study in high bleeding risk patients.

    La Jolla, California and other locations

Last updated: